0
RCReports CornerKidney Cancer (Renal Cell Cancer) - PipelineReview, H1 2013
DescriptionDescriptionReports Cornerwww.reportscorner.comGlobal Markets Directs, Kidney Cancer (Renal Cell Cancer) -Pipeli...
Brief SummaryBrief SummaryReports Cornerwww.reportscorner.comGlobal Markets Directs, Kidney Cancer (Renal Cell Cancer) -Pi...
Brief SummaryBrief SummaryReports Cornerwww.reportscorner.comScope- A snapshot of the global therapeutic scenario for Kidn...
Brief SummaryBrief SummaryReports Cornerwww.reportscorner.comReasons to buy- Identify and understand important and diverse...
Brief SummaryBrief SummaryReports Cornerwww.reportscorner.com- Modify the therapeutic portfolio by identifying discontinue...
Table of ContentsTable of ContentsReports Cornerwww.reportscorner.comTable of ContentsTable of Contents 2Introduction 7Kid...
Table of ContentsTable of ContentsReports Cornerwww.reportscorner.comCompanies Involved in Kidney Cancer (Renal Cell Cance...
For more informationFor more informationReports Cornerwww.reportscorner.comFor more information please visit our websiteht...
Reports CornerThank YouThank Youwww.reportscorner.comRCContact us: contact@reportscorner.com
Upcoming SlideShare
Loading in...5
×

Kidney cancer (renal cell cancer) pipeline review, h1 2013 - Reports Corner

408

Published on

Global Markets Direct's, 'Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Kidney Cancer (Renal Cell Cancer), complete with latest updates, and special features on late-stage and discontinued projects.

https://www.reportscorner.com/reports/15415/Kidney-Cancer-(Renal-Cell-Cancer)---Pipeline-Review,-H1-2013/

Published in: Health & Medicine, Business
0 Comments
1 Like
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total Views
408
On Slideshare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
11
Comments
0
Likes
1
Embeds 0
No embeds

No notes for slide

Transcript of "Kidney cancer (renal cell cancer) pipeline review, h1 2013 - Reports Corner"

  1. 1. RCReports CornerKidney Cancer (Renal Cell Cancer) - PipelineReview, H1 2013
  2. 2. DescriptionDescriptionReports Cornerwww.reportscorner.comGlobal Markets Directs, Kidney Cancer (Renal Cell Cancer) -Pipeline Review, H1 2013, provides an overview of theindications therapeutic pipeline. This report provides informationon the therapeutic development for Kidney Cancer (Renal CellCancer), complete with latest updates, and special features onlate-stage and discontinued projects.
  3. 3. Brief SummaryBrief SummaryReports Cornerwww.reportscorner.comGlobal Markets Directs, Kidney Cancer (Renal Cell Cancer) -Pipeline Review, H1 2013, provides an overview of theindications therapeutic pipeline. This report provides informationon the therapeutic development for Kidney Cancer (Renal CellCancer), complete with latest updates, and special features onlate-stage and discontinued projects. It also reviews key playersinvolved in the therapeutic development for Kidney Cancer (RenalCell Cancer). Kidney Cancer (Renal Cell Cancer) - Pipeline Review,Half Year is built using data and information sourced from GlobalMarkets Directs proprietary databases, Company/Universitywebsites, SEC filings, investor presentations and featured pressreleases from company/university sites and industry-specific thirdparty sources, put together by Global Markets Directs team.Note*: Certain sections in the report may be removed or alteredbased on the availability and relevance of data for the indicateddisease.
  4. 4. Brief SummaryBrief SummaryReports Cornerwww.reportscorner.comScope- A snapshot of the global therapeutic scenario for Kidney Cancer(Renal Cell Cancer).- A review of the Kidney Cancer (Renal Cell Cancer) productsunder development by companies and universities/researchinstitutes based on information derived from company andindustry-specific sources.- Coverage of products based on various stages of developmentranging from discovery till registration stages.- A feature on pipeline projects on the basis of monotherapy andcombined therapeutics.- Coverage of the Kidney Cancer (Renal Cell Cancer) pipeline onthe basis of route of administration and molecule type.- Key discontinued pipeline projects.- Latest news and deals relating to the products.
  5. 5. Brief SummaryBrief SummaryReports Cornerwww.reportscorner.comReasons to buy- Identify and understand important and diverse types oftherapeutics under development for Kidney Cancer (Renal CellCancer).- Identify emerging players with potentially strong productportfolio and design effective counter-strategies to gaincompetitive advantage.- Plan mergers and acquisitions effectively by identifying playersof the most promising pipeline.- Devise corrective measures for pipeline projects byunderstanding Kidney Cancer (Renal Cell Cancer) pipeline depthand focus of Indication therapeutics.- Develop and design in-licensing and out-licensing strategies byidentifying prospective partners with the most attractive projectsto enhance and expand business potential and scope.
  6. 6. Brief SummaryBrief SummaryReports Cornerwww.reportscorner.com- Modify the therapeutic portfolio by identifying discontinuedprojects and understanding the factors that drove them frompipeline.portfolio by identifying discontinued projects and understandingthe factors that drove them from pipeline.
  7. 7. Table of ContentsTable of ContentsReports Cornerwww.reportscorner.comTable of ContentsTable of Contents 2Introduction 7Kidney Cancer (Renal Cell Cancer) Overview 8Therapeutics Development 9Kidney Cancer (Renal Cell Cancer) Therapeutics under Development by Companies 11Kidney Cancer (Renal Cell Cancer) Therapeutics under Investigation by Universities/Institutes 18Late Stage Products 21Mid Clinical Stage Products 22Early Clinical Stage Products 23Discovery and Pre-Clinical Stage Products 24Kidney Cancer (Renal Cell Cancer) Therapeutics - Products under Development by Companies 25Kidney Cancer (Renal Cell Cancer) Therapeutics - Products under Investigation by Universities/Institutes34
  8. 8. Table of ContentsTable of ContentsReports Cornerwww.reportscorner.comCompanies Involved in Kidney Cancer (Renal Cell Cancer) Therapeutics Development 37Kidney Cancer (Renal Cell Cancer) - Therapeutics Assessment 115Drug Profiles 122Kidney Cancer (Renal Cell Cancer) Therapeutics - Drug Profile Updates 366Kidney Cancer (Renal Cell Cancer) Therapeutics - Discontinued Products 454Kidney Cancer (Renal Cell Cancer) Therapeutics - Dormant Products 457Kidney Cancer (Renal Cell Cancer) - Product Development Milestones 466Appendix 476
  9. 9. For more informationFor more informationReports Cornerwww.reportscorner.comFor more information please visit our websitehttps://www.reportscorner.com/reports/15415/Kidney-Cancer-(Renal-Cell-Cancer)---Pipeline-Review,-H1-2013/
  10. 10. Reports CornerThank YouThank Youwww.reportscorner.comRCContact us: contact@reportscorner.com
  1. A particular slide catching your eye?

    Clipping is a handy way to collect important slides you want to go back to later.

×